SPA
IDXX icon

Sherbrooke Park Advisers’s Idexx Laboratories IDXX Stock Holding History

Sherbrooke Park Advisers’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-1,017
Closed -$420K – 757
2024
Q4 		$420K Sell
1,017
-585
-37% -$257K 0.13% 273
2024
Q3 		$809K Buy
+1,602
New +$778K 0.19% 133
2024
Q2 		– Sell
-1,574
Closed -$850K – 1050
2024
Q1 		$850K Buy
+1,574
New +$860K 0.17% 188
2023
Q4 		– Sell
-798
Closed -$349K – 572
2023
Q3 		$349K Buy
+798
New +$398K 0.11% 309

Other funds holding IDXX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

Sherbrooke Park Advisers's IDXX Position: Q1 2025 in Review

Sherbrooke Park Advisers sold out of Idexx Laboratories (IDXX) in Q1 2025, closing a stake of 1,017 shares — an estimated $420K sold.

Sherbrooke Park Advisers first reported a position in IDXX in Q3 2023 and held it in 4 quarters. The position peaked at $850K in Q1 2024. 1,142 funds tracked by Wall St. Rank hold IDXX as of Q1 2025.

  • Sherbrooke Park Advisers reported no remaining Idexx Laboratories position as of Q1 2025 after selling out during the quarter.
  • Sherbrooke Park Advisers sold 1,017 Idexx Laboratories shares in Q1 2025, an estimated $420K.
  • Sherbrooke Park Advisers first reported a position in Idexx Laboratories in Q3 2023 and held it in 4 quarters.
  • Sherbrooke Park Advisers's Idexx Laboratories position peaked at $850K in Q1 2024.
  • 1,142 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2025.

Based on Sherbrooke Park Advisers's 13F filing for Q1 2025, filed 15 May 2025.